Clinical Significance of Endometrial Cells in Pap Smear of Women Aged 40 Years and Older

Objective: To investigate the histopathological follow-up results in women diagnosed with endometrial cells in the Papanicolaou (Pap) test. Material and Method: Between January 2013 to December 2018, women with endometrial cells on the Pap test were searched from the hospital electronic database. T...

Full description

Bibliographic Details
Main Authors: Esra KELEŞ, Uğur Kemal ÖZTÜRK, Cihat Murat ALINCA, Serkan AKIŞ, Canan KABACA, Handan ÇETINER
Format: Article
Language:English
Published: Federation of Turkish Pathology Societies 2022-09-01
Series:Türk Patoloji Dergisi
Subjects:
Online Access: http://www.turkjpath.org/pdf.php3?id=2006
_version_ 1797908713763241984
author Esra KELEŞ
Uğur Kemal ÖZTÜRK
Cihat Murat ALINCA
Serkan AKIŞ
Canan KABACA
Handan ÇETINER
author_facet Esra KELEŞ
Uğur Kemal ÖZTÜRK
Cihat Murat ALINCA
Serkan AKIŞ
Canan KABACA
Handan ÇETINER
author_sort Esra KELEŞ
collection DOAJ
description Objective: To investigate the histopathological follow-up results in women diagnosed with endometrial cells in the Papanicolaou (Pap) test. Material and Method: Between January 2013 to December 2018, women with endometrial cells on the Pap test were searched from the hospital electronic database. The patients with endometrial cells on the Pap test who underwent further histopathological evaluation and who were followed-up for at least 1 year were enrolled in the study, while those who had a Pap test result other than endometrial cells, were lost during follow-up, or had missing data were excluded. Results: Out of 91,142 Pap smears, 121 (0.1%) cytologically had endometrial cells, and of those 65 cases were eligible for final analysis. The mean age of patients with premalignant/malignant lesions (57.7 ± 2.9) was higher than those with benign lesions (50.1 ± 0.7), with 77% of them in the postmenopausal period. Gynecologic premalignant/malignant lesions were detected in 9 (17.7%) patients including 2 (3.1%) endometrial hyperplasias and 7 (10.8%) endometrial cancers. The menopausal status (p=0.010) and being 50 years and older (p=0.002) were significantly associated with pre-neoplastic or neoplastic changes in patients with endometrial cells. Conclusion: The presence of endometrial cells in Pap tests may be a harbinger of endometrial pathologies, especially at the age of 50 years and over. The menopausal status is another possible determinant in detecting endometrial carcinoma. Further investigation may be suggested in women aged ≥50 years and postmenopausal in the event of endometrial cell detection.
first_indexed 2024-04-10T10:58:10Z
format Article
id doaj.art-ee017a1b950d4e3988b0fe988dc44317
institution Directory Open Access Journal
issn 1018-5615
1309-5730
language English
last_indexed 2024-04-10T10:58:10Z
publishDate 2022-09-01
publisher Federation of Turkish Pathology Societies
record_format Article
series Türk Patoloji Dergisi
spelling doaj.art-ee017a1b950d4e3988b0fe988dc443172023-02-15T16:19:51ZengFederation of Turkish Pathology SocietiesTürk Patoloji Dergisi1018-56151309-57302022-09-0138323523910.5146/tjpath.2022.01570Clinical Significance of Endometrial Cells in Pap Smear of Women Aged 40 Years and OlderEsra KELEŞUğur Kemal ÖZTÜRKCihat Murat ALINCASerkan AKIŞCanan KABACAHandan ÇETINERObjective: To investigate the histopathological follow-up results in women diagnosed with endometrial cells in the Papanicolaou (Pap) test. Material and Method: Between January 2013 to December 2018, women with endometrial cells on the Pap test were searched from the hospital electronic database. The patients with endometrial cells on the Pap test who underwent further histopathological evaluation and who were followed-up for at least 1 year were enrolled in the study, while those who had a Pap test result other than endometrial cells, were lost during follow-up, or had missing data were excluded. Results: Out of 91,142 Pap smears, 121 (0.1%) cytologically had endometrial cells, and of those 65 cases were eligible for final analysis. The mean age of patients with premalignant/malignant lesions (57.7 ± 2.9) was higher than those with benign lesions (50.1 ± 0.7), with 77% of them in the postmenopausal period. Gynecologic premalignant/malignant lesions were detected in 9 (17.7%) patients including 2 (3.1%) endometrial hyperplasias and 7 (10.8%) endometrial cancers. The menopausal status (p=0.010) and being 50 years and older (p=0.002) were significantly associated with pre-neoplastic or neoplastic changes in patients with endometrial cells. Conclusion: The presence of endometrial cells in Pap tests may be a harbinger of endometrial pathologies, especially at the age of 50 years and over. The menopausal status is another possible determinant in detecting endometrial carcinoma. Further investigation may be suggested in women aged ≥50 years and postmenopausal in the event of endometrial cell detection. http://www.turkjpath.org/pdf.php3?id=2006 endometrial cellsendometrial cancerpapanicolaou (pap) testthe bethesda system
spellingShingle Esra KELEŞ
Uğur Kemal ÖZTÜRK
Cihat Murat ALINCA
Serkan AKIŞ
Canan KABACA
Handan ÇETINER
Clinical Significance of Endometrial Cells in Pap Smear of Women Aged 40 Years and Older
Türk Patoloji Dergisi
endometrial cells
endometrial cancer
papanicolaou (pap) test
the bethesda system
title Clinical Significance of Endometrial Cells in Pap Smear of Women Aged 40 Years and Older
title_full Clinical Significance of Endometrial Cells in Pap Smear of Women Aged 40 Years and Older
title_fullStr Clinical Significance of Endometrial Cells in Pap Smear of Women Aged 40 Years and Older
title_full_unstemmed Clinical Significance of Endometrial Cells in Pap Smear of Women Aged 40 Years and Older
title_short Clinical Significance of Endometrial Cells in Pap Smear of Women Aged 40 Years and Older
title_sort clinical significance of endometrial cells in pap smear of women aged 40 years and older
topic endometrial cells
endometrial cancer
papanicolaou (pap) test
the bethesda system
url http://www.turkjpath.org/pdf.php3?id=2006
work_keys_str_mv AT esrakeles clinicalsignificanceofendometrialcellsinpapsmearofwomenaged40yearsandolder
AT ugurkemalozturk clinicalsignificanceofendometrialcellsinpapsmearofwomenaged40yearsandolder
AT cihatmuratalinca clinicalsignificanceofendometrialcellsinpapsmearofwomenaged40yearsandolder
AT serkanakis clinicalsignificanceofendometrialcellsinpapsmearofwomenaged40yearsandolder
AT canankabaca clinicalsignificanceofendometrialcellsinpapsmearofwomenaged40yearsandolder
AT handancetiner clinicalsignificanceofendometrialcellsinpapsmearofwomenaged40yearsandolder